Flagship Ventures Fund 2004 L P

CIK 1299790 · last filed 2008-12-29

Flagship Ventures Fund 2004 L P is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing, for HLCS, was dated Dec 29, 2008. The firm reports its address in Cambridge, MA. 15 SEC filings were submitted jointly with Flagship Ventures General Partner LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

55 CAMBRIDGE PARKWAY, 8TH FLOOR
CAMBRIDGE, MA 02142

Phone

(617) 868-1888

Related Filers

Flagship Ventures General Partner LLC — 15 joint filings, latest 2017-12-13

Edwin Kania — 14 joint filings, latest 2017-12-13

NOUBAR AFEYAN — 9 joint filings, latest 2017-12-13

Flagship Pioneering Inc. — 7 joint filings, latest 2009-09-22

Applied Genomic Technology Capital Fund LP — 6 joint filings, latest 2009-08-10

NewcoGen Group, Inc. — 4 joint filings, latest 2009-09-22

AGTC ADVISORS FUND LP — 3 joint filings, latest 2008-12-29

Flagship Ventures 2007 General Partner LLC — 2 joint filings, latest 2013-03-27

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
HELICOS BIOSCIENCES CORP (HLCS) Delisted	Director	11,949,709	—	—	$0	1	2008-12-29

Recent Filings

1 filing

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2008-12-29	HELICOS BIOSCIENCES CORP (HLCS) Delisted	Buy (P)	+51,724,140	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.